Los Angeles Capital Management Portfolio holdings
AUM
$26.7B
1-Year Return
35.08%
This Quarter Return
+19.76%
1 Year Return
+35.08%
3 Year Return
+164.18%
5 Year Return
+293.76%
10 Year Return
+832%
AUM
$26.7B
AUM Growth
+$4.09B
(+18%)
Cap. Flow
+$946M
Cap. Flow
% of AUM
3.54%
Top 10 Holdings %
Top 10 Hldgs %
38.79%
Holding
1,469
New
391
Increased
391
Reduced
480
Closed
149
Top Buys
| 1 |
Veeva Systems
VEEV
|
+$196M |
| 2 |
NVIDIA
NVDA
|
+$194M |
| 3 |
GE Aerospace
GE
|
+$151M |
| 4 |
Walt Disney
DIS
|
+$147M |
| 5 |
ServiceNow
NOW
|
+$144M |
Top Sells
| 1 |
Motorola Solutions
MSI
|
+$135M |
| 2 |
Cisco
CSCO
|
+$127M |
| 3 |
Amazon
AMZN
|
+$118M |
| 4 |
US Bancorp
USB
|
+$117M |
| 5 |
Charles Schwab
SCHW
|
+$96.2M |
Sector Composition
| 1 | Technology | 34.4% |
| 2 | Communication Services | 13.42% |
| 3 | Financials | 12.74% |
| 4 | Healthcare | 10.59% |
| 5 | Industrials | 9.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1301
Tango Therapeutics
TNGX
$727M
| $52.7K | ﹤0.01% |
10,290
-118,820
| -92% | -$608K |
|
1302
Cytek Biosciences
CTKB
$501M
| $52.1K | ﹤0.01% |
+15,332
| New | +$52.1K |
|
1303
Definitive Healthcare
DH
$432M
| $51.1K | ﹤0.01% |
+13,110
| New | +$51.1K |
|
1304
Voyager Therapeutics
VYGR
$232M
| $50.3K | ﹤0.01% |
+16,180
| New | +$50.3K |
|
1305
Annexon
ANNX
$266M
| $48.5K | ﹤0.01% |
+20,196
| New | +$48.5K |
|
1306
Geron
GERN
$810M
| $48.2K | ﹤0.01% |
34,174
| – | – |
|
1307
Siebert Financial
SIEB
$118M
| $47.6K | ﹤0.01% |
+10,760
| New | +$47.6K |
|
1308
Esperion Therapeutics
ESPR
$573M
| $47.4K | ﹤0.01% |
48,172
| – | – |
|
1309
Holley
HLLY
$370M
| $47.2K | ﹤0.01% |
+23,580
| New | +$47.2K |
|
1310
Protara Therapeutics
TARA
$121M
| $47.1K | ﹤0.01% |
+15,545
| New | +$47.1K |
|
1311
Vaalco Energy
EGY
$419M
| $46.5K | ﹤0.01% |
12,870
-84,620
| -87% | -$305K |
|
1312
Y-mAbs Therapeutics
YMAB
$390M
| $46.4K | ﹤0.01% |
+10,284
| New | +$46.4K |
|
1313
loanDepot
LDI
$894M
| $46.3K | ﹤0.01% |
+36,450
| New | +$46.3K |
|
|
CRGX
1314
DELISTED
CARGO Therapeutics
CRGX
| $45.9K | ﹤0.01% |
+11,150
| New | +$45.9K |
|
1315
Erasca
ERAS
$443M
| $44.5K | ﹤0.01% |
+35,075
| New | +$44.5K |
|
1316
Design Therapeutics
DSGN
$343M
| $42.9K | ﹤0.01% |
+12,735
| New | +$42.9K |
|
1317
4D Molecular Therapeutics
FDMT
$318M
| $41.8K | ﹤0.01% |
+11,280
| New | +$41.8K |
|
1318
Allogene Therapeutics
ALLO
$251M
| $40.6K | ﹤0.01% |
+35,970
| New | +$40.6K |
|
1319
Agilon Health
AGL
$443M
| $37.3K | ﹤0.01% |
16,223
-114,256
| -88% | -$263K |
|
1320
Stoneridge
SRI
$228M
| – | – |
-67,572
| Closed | -$310K |
|
1321
Shutterstock
SSTK
$742M
| – | – |
-23,841
| Closed | -$444K |
|
1322
Stellar Bancorp
STEL
$1.61B
| – | – |
-8,225
| Closed | -$228K |
|
1323
StepStone Group
STEP
$4.87B
| – | – |
-20,177
| Closed | -$1.05M |
|
1324
TAL Education Group
TAL
$6.67B
| – | – |
-324,794
| Closed | -$4.29M |
|
1325
Bio-Techne
TECH
$7.97B
| – | – |
-7,335
| Closed | -$430K |
|